Labcorp Holdings Inc (纽交所代码:LH)总裁兼首席执行官Adam H. Schechter于2026年3月3日以每股$279.9595的价格出售了8,705股普通股,交易总额约为244万美元。此次交易后,Schechter直接持有Labcorp 80,773股股票。此次出售正值Labcorp股价接近其52周高点$293.72,今年迄今股价上涨12%。该股目前市盈率为26.91 ...
根据向美国证券交易委员会提交的Form 4文件,Labcorp Holdings Inc(纽交所代码:LH)企业事务执行副总裁Sandra D. van der Vaart于2026年2月27日出售了547.5397股普通股。 这些股票的出售价格为284.91美元,交易总价值为155,999美元。交易完成后,van der Vaart直接持有Labcorp Holdings Inc 2578.94 ...
In February 2026, Labcorp Holdings Inc. reported past fourth-quarter 2025 sales of US$3,515.8 million and net income of US$164.7 million, alongside full-year 2025 sales of US$13.95 billion and net ...
Laboratory Corp (NYSE: LH) reported third-quarter 2025 adjusted earnings per share of $4.18 on Tuesday, up from $3.50 a year ago, beating the consensus of $4.18. Sales increased 8.6% year-over-year to ...
(LH) on Tuesday reported fourth-quarter profit of $164.7 million. The Burlington, North Carolina-based company said it had ...
StockStory.org on MSN
Labcorp (NYSE:LH) misses Q4 CY2025 sales expectations
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q4 CY2025, but sales rose 5.6% year on year to $3.52 billion. On ...
LH eyes growth via specialty test expansion, acquisitions and LaunchPad savings, but currency headwinds and macro pressures cloud the outlook.
BURLINGTON, N.C., Sept. 25, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third ...
BURLINGTON, N.C., March 31, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果